Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis

Clinical trial NCT00095498 · COMPLETED

Trial details

NCT number: NCT00095498
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2004-08-11
Primary completion: 2007-04-01
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.